Ikena Oncology Total Liabilities

Ikena Oncology (IKNA) currently reports a total liabilities of $10M as of June 2026. That compares with $10M in the prior-year period — down 2.8% year over year. Use the charts on this page to explore Ikena Oncology's total liabilities history and peer comparisons.

Ikena Oncology's total liabilities decreased from $10M to $10M — a 2.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ikena Oncology reported $10M in total liabilities as of June 2026. That compares with $10M in the prior-year period — down 2.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $10M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ikena Oncology, and consider following IKNA for alerts when major investors trade the stock.

Ikena Oncology is classified in the Healthcare sector. On total liabilities, it currently shows $10M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IKNA with unrelated industries.